Immunosenescence: molecular mechanisms and diseases
- PMID: 37179335
- PMCID: PMC10182360
- DOI: 10.1038/s41392-023-01451-2
Immunosenescence: molecular mechanisms and diseases
Abstract
Infection susceptibility, poor vaccination efficacy, age-related disease onset, and neoplasms are linked to innate and adaptive immune dysfunction that accompanies aging (known as immunosenescence). During aging, organisms tend to develop a characteristic inflammatory state that expresses high levels of pro-inflammatory markers, termed inflammaging. This chronic inflammation is a typical phenomenon linked to immunosenescence and it is considered the major risk factor for age-related diseases. Thymic involution, naïve/memory cell ratio imbalance, dysregulated metabolism, and epigenetic alterations are striking features of immunosenescence. Disturbed T-cell pools and chronic antigen stimulation mediate premature senescence of immune cells, and senescent immune cells develop a proinflammatory senescence-associated secretory phenotype that exacerbates inflammaging. Although the underlying molecular mechanisms remain to be addressed, it is well documented that senescent T cells and inflammaging might be major driving forces in immunosenescence. Potential counteractive measures will be discussed, including intervention of cellular senescence and metabolic-epigenetic axes to mitigate immunosenescence. In recent years, immunosenescence has attracted increasing attention for its role in tumor development. As a result of the limited participation of elderly patients, the impact of immunosenescence on cancer immunotherapy is unclear. Despite some surprising results from clinical trials and drugs, it is necessary to investigate the role of immunosenescence in cancer and other age-related diseases.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Contributions of Age-Related Thymic Involution to Immunosenescence and Inflammaging.Immun Ageing. 2020 Jan 20;17:2. doi: 10.1186/s12979-020-0173-8. eCollection 2020. Immun Ageing. 2020. PMID: 31988649 Free PMC article. Review.
-
Immunosenescence, inflammaging, and cancer immunotherapy efficacy.Expert Rev Anticancer Ther. 2022 Sep;22(9):915-926. doi: 10.1080/14737140.2022.2098718. Epub 2022 Jul 14. Expert Rev Anticancer Ther. 2022. PMID: 35815381 Review.
-
Senescent cell-derived extracellular vesicles as potential mediators of innate immunosenescence and inflammaging.Exp Gerontol. 2024 Mar;187:112365. doi: 10.1016/j.exger.2024.112365. Epub 2024 Jan 24. Exp Gerontol. 2024. PMID: 38237747 Review.
-
Counteracting Immunosenescence-Which Therapeutic Strategies Are Promising?Biomolecules. 2023 Jul 6;13(7):1085. doi: 10.3390/biom13071085. Biomolecules. 2023. PMID: 37509121 Free PMC article. Review.
-
The Role of Immunosenescence in the Development of Age-Related Diseases.Rev Invest Clin. 2016 Mar-Apr;68(2):84-91. Rev Invest Clin. 2016. PMID: 27103044 Review.
Cited by
-
The Aging Immune System: A Critical Attack on Ischemic Stroke.Mol Neurobiol. 2024 Sep 14. doi: 10.1007/s12035-024-04464-2. Online ahead of print. Mol Neurobiol. 2024. PMID: 39271626 Review.
-
Turning to immunosuppressive tumors: Deciphering the immunosenescence-related microenvironment and prognostic characteristics in pancreatic cancer, in which GLUT1 contributes to gemcitabine resistance.Heliyon. 2024 Aug 22;10(17):e36684. doi: 10.1016/j.heliyon.2024.e36684. eCollection 2024 Sep 15. Heliyon. 2024. PMID: 39263146 Free PMC article.
-
Ageing results in an exacerbated inflammatory response to LPS by resident lung cells.Immun Ageing. 2024 Sep 12;21(1):62. doi: 10.1186/s12979-024-00467-8. Immun Ageing. 2024. PMID: 39261941 Free PMC article.
-
The emerging links between immunosenescence in innate immune system and neurocryptococcosis.Front Immunol. 2024 Aug 20;15:1410090. doi: 10.3389/fimmu.2024.1410090. eCollection 2024. Front Immunol. 2024. PMID: 39229268 Free PMC article. Review.
-
Effect of Menopausal Hormone Therapy on Cellular Immunity Parameters and Cytokine Profile.Biomedicines. 2024 Aug 19;12(8):1892. doi: 10.3390/biomedicines12081892. Biomedicines. 2024. PMID: 39200355 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials